β-catenin Activators

β-catenin activators constitute a distinctive class of chemical compounds that primarily exert their biological effects through modulation of the Wnt/β-catenin signaling pathway, a major cellular mechanism responsible for regulating various physiological processes including cell proliferation, differentiation, migration, and survival. The β-catenin protein serves as a key player within this pathway and functions as a crucial co-transcriptional activator, becoming stabilized and translocating to the nucleus to initiate the transcription of Wnt target genes upon Wnt signal reception. β-catenin activators, therefore, are molecules that directly or indirectly stimulate the accumulation, stabilization, or activity of β-catenin, thereby amplifying the Wnt/β-catenin signaling cascade.

The β-catenin activators encompass a diverse array of compounds with varied structures and mechanisms of action. Some of these activators function by inhibiting Glycogen Synthase Kinase 3 beta (GSK-3β), a kinase that phosphorylates β-catenin leading to its ubiquitination and degradation. Inhibition of GSK-3β by these activators results in the stabilization and accumulation of β-catenin. Examples of such compounds include Lithium Chloride and 6-Bromoindirubin-3'-oxime. Other activators, such as Wnt3a, bind to Frizzled receptors and LRP5/6 co-receptors, activating Dishevelled proteins that inhibit GSK-3β, thus leading to increased β-catenin levels. Yet another class of β-catenin activators function by inhibiting the interaction of β-catenin with its negative regulators, such as ICG-001 which inhibits the interaction of β-catenin with CREB-binding protein (CBP). Despite the differences in their mechanisms of action, all these compounds share the common feature of potentiating β-catenin and thus enhancing Wnt/β-catenin signaling.